Feasibility of At-Home Telehealth Yoga for Treating Chronic Pain

March 22, 2023 updated by: Peter Bayley, Palo Alto Veterans Institute for Research
This feasibility study will evaluate yoga as a treatment for chronic musculoskeletal pain. The experimental treatment is yoga delivered via a tablet computer to participants at home ("teleyoga"). First, the investigators will develop a suitable protocol for teleyoga. Second, the investigators will demonstrate the feasibility of conducting a randomized controlled trial involving randomization to teleyoga or in-person yoga groups.

Study Overview

Detailed Description

The first phase of the study is not randomized. In this phase, the first group of participants (n=10) will all participate in a tele-yoga class using an iPad loaned to them by the study. They will attend this treatment session from the comfort of their home or a location of their choice. Yoga treatment will last 12 weeks. At the end of treatment, veterans will provide feedback by completing a satisfaction questionnaire to rate various aspects of the teleyoga (e.g. technical challenges, ability to perform yoga through the video-conferencing platform, problems that occurred, and recommendations to improve the class, etc). The teleyoga protocol will be modified on the basis of this feedback and will be tested on a second group of participants (n=10). The second phase of the study will involve randomization of a further group of participants (n=30) to either the teleyoga developed in phase one, or in-person yoga.

Study Type

Interventional

Enrollment (Actual)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Palo Alto, California, United States, 94304
        • VA Palo Alto Health Care System

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Veteran
  • Medical clearance for participation by VA primary care provider
  • Diagnosis of musculoskeletal pain > 6 months
  • Minimum pain intensity of 4 at screening on 0-10 scale
  • Any psychotropic treatments stable for at least 4 weeks before study
  • English literacy
  • Wireless Internet connection at home

Exclusion Criteria:

  • Current participation in another clinical trial
  • Back surgery within the last 12 months
  • Back pain related to a specific underlying cause, disease, or condition
  • Baseline pain <4 or >9 on 0-10 scale
  • Unstable, serious coexisting medical illness
  • Unstable, serious coexisting mental illness
  • Attended or practiced yoga ≥1 time in the past 12 months
  • Active current suicidal plan or intent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Teleyoga
group will receive instruction via computer tablet
the yoga protocol will be delivered via a tablet computer to groups of participants
Active Comparator: In-person yoga
group will receive instruction in-person
the yoga protocol will be delivered by a yoga instructor in the room to group of participants

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Multi-Dimensional Treatment Satisfaction Measure
Time Frame: after 12 weeks of treatment
A participant satisfaction measure [score range: 0 to 4]. The higher the value, the greater the treatment satisfaction
after 12 weeks of treatment
Adherence to the Treatment Protocol
Time Frame: during 12 weeks of treatment
% of randomized patients who attend ≥65% of treatment sessions
during 12 weeks of treatment
Attrition
Time Frame: during 12 weeks of treatment
number of randomized patients who drop out of treatment
during 12 weeks of treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence to the treatment protocol
Time Frame: at study completion, an average of 2 years
% of randomized patients who attend ≥65% of treatment sessions
at study completion, an average of 2 years
Rate of attrition
Time Frame: at study completion, an average of 2 years
% of randomized patients who drop out of treatment
at study completion, an average of 2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 6, 2019

Primary Completion (Actual)

December 17, 2021

Study Completion (Actual)

December 17, 2021

Study Registration Dates

First Submitted

August 5, 2019

First Submitted That Met QC Criteria

August 27, 2019

First Posted (Actual)

August 29, 2019

Study Record Updates

Last Update Posted (Actual)

April 18, 2023

Last Update Submitted That Met QC Criteria

March 22, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • BAY0006AGG
  • R34AT010364 (U.S. NIH Grant/Contract)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Pain

Clinical Trials on Teleyoga

Subscribe